DUBAI, United Arab Emirates, Oct. 27, 2025 (GLOBE NEWSWIRE) — For the first time, the human body's most complex data—the complex interactions between our genes, proteins, and metabolites—can be understood not as isolated signals, but as a coherent language. Today BioAro Inc. announces a historic leap in artificial intelligence: the world's first large language model (LLM) built on unified multi-omics data. This is the core “Biointelligence™” powers its flagship platform, PanOmiK™which will be presented at the World Health Expo in Riyadh, offering a new paradigm in which biology is not just measured, but truly understood.
The main disadvantage of modern medicine is fragmentation. We are drowning in data—genomic snapshots, proteomic profiles, metabolomic readouts—but we lack the translator to make sense of their collective history. This piecemeal approach obscures the causes of complex diseases like cancer and diabetes, delaying treatment and personalizing care.
PanOmiK™ destroys these bunkers. Its multi-omics LLM, trained on the complete vocabulary of human biology, deciphers the subtle, nonlinear interactions that define health and disease. It doesn't just analyze data points; he interprets the biological narrative, revealing root causes and predictive insights with a speed and clarity previously unimaginable.
“We have moved from counting words to understanding poetry—poetry written in the language of our own cells,” said Dr. Anmol Kapoor, founder and CEO of BioAro. “The core of the new healthcare ecosystem isBioIntellect™'. It transforms disparate data into a coherent dialogue between patients and their own biology, finally making proactive and predictable health a practical reality.”
Safe fortress for the most personal data
Understanding that our most sensitive data – our genetic program – requires the highest security, BioAro developed PanOmiK™ for local deployment. Using Powerful Fusion FPGA acceleration and GPU When computing, the platform operates as an autonomous intelligent unit within the walls of a hospital or laboratory.
- Your data will never disappear: In the era of cloud vulnerabilities PanOmiK™ guarantees absolute data sovereignty. It ensures full compliance with GDPR, HIPAA and local regulations, keeping the world's most personal information securely in place.
- Speed where it matters most: By processing data at the edge, the platform eliminates critical latency upload to the cloud. What takes weeks using traditional, standalone tools, PanOmiK™ achieved in a matter of hours thanks to parallel processing and faster treatment and detection times.
- Truly Certified Precision: The platform has reached 100% accuracy in KAP proficiency testing to ensure its revolutionary speed is combined with rock-solid reliability using industry-standard guidelines.
BioIntelligence™ Ecosystem: A United Front for Healthcare
Based on the LLM multi-omics core, BioIntellect™ feeds a set of specialized tools that work in concert:
- Genelio™: This is where the magic of LLM becomes personal. Genelio™ allows people to have natural chat conversations with their own genomic and health data. Users may ask questions such as “Why am I at higher risk for heart disease?” or “What does this genetic variant mean for my children?” and receive clear, conversational answers derived directly from their unique biological profile, making complex science accessible and empowering.
- PanAUM™: AI-powered AI in silica a drug discovery environment that predicts molecular interactions and accelerates the identification of therapeutic candidates.
- BioLIMS™: A next-generation end-to-end laboratory system that seamlessly transfers structured data to the analytical engine.
- BioELR™: Integrates wearables, sensors and health apps to provide real-time, AI-powered insights for chronic disease management and preventive care.
Introducing Axion™ – the BioIntelligence Series
To ensure the full functioning of this ecosystem, Axion™ The series is a patented family of intelligent hardware systems designed to enable local, FPGA-accelerated, and independent artificial intelligence computing for medical and research environments.
Axion™ line – Core, Ultra and Supreme – Enables hospitals, research institutions and national health programs to seamlessly deploy technology, with each layer tailored to different operational and data processing needs.
Together, Axion™ And PanOmiK™ redefine speed, sovereignty and scalability, ensuring the medicine of the future can work anywhere, safely and smartly.
“For the UAE and the entire Gulf region, which prioritizes both technology leadership and data sovereignty, this is a transformative decision,” he said. Bader al-Marzuqileading healthcare investor in the Emirates. “BioAro doesn't just import technology; it delivers sovereign capabilities that align with our national vision for a safe, innovative and proactive future of healthcare. It empowers our physicians while protecting our citizens' data.”
Demonstration at the Global Health exhibition in Riyadh
On Global Health Exhibition in RiyadhBioAro will show strength ecosystem – show live conversation with Genelio™and in real time multi-omics analysis using PanOmiQ™.
“We're not just launching a product, we're launching a movement—from reactive guesswork to proactive, smart health,” Dr. Kapoor said. “The future of medicine speaks the language of life itself, and we are proud to give it a voice in Riyadh.”
About BioAro Inc.
BioAro Inc. is a Canadian software and biotechnology company creating the future of intelligent and independent healthcare. Its mission is to combine biology and data science through Biointelligence™bridging the gap between complex molecular information and actionable, personalized health insights.
Media contact:
Mohini
E-mail: [email protected]
Phone: +1-403-250-2221
For more information visit: www.PanOmiQ.com | www.BioAro.com
Photos accompanying this announcement are available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/83d816d2-5608-4ef8-a36f-bf9d55cda525
https://www.globenewswire.com/NewsRoom/AttachmentNg/18aa3fb2-b13e-4a25-a7cb-4557cba39e89
